ProfileGDS4718 / 41037_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 50% 41% 22% 48% 33% 83% 76% 40% 36% 45% 49% 33% 67% 78% 79% 59% 44% 70% 77% 68% 46% 51% 51% 44% 47% 74% 39% 66% 48% 68% 71% 70% 29% 41% 88% 85% 76% 51% 41% 37% 42% 67% 62% 85% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]5.5275850
GSM549102patient 115, normal, homogenized [OPG study]5.0755141
GSM549104patient 119, normal, homogenized [OPG study]4.1908622
GSM549108patient 138, normal, homogenized [OPG study]5.4641348
GSM549119patient 077, normal, homogenized [OPG study]4.6800933
GSM549133patient 032, cancer, homogenized [OPG study]8.3471283
GSM549139patient 042, cancer, homogenized [OPG study]7.4479576
GSM549099patient 107, normal, homogenized [OPG study]5.0077940
GSM549109patient 139, normal, homogenized [OPG study]4.8245936
GSM549110patient 046, normal, homogenized [OPG study]5.2302545
GSM549114patient 063, normal, homogenized [OPG study]5.4238349
GSM549122patient 082, normal, homogenized [OPG study]4.6636833
GSM549134patient 033, cancer, homogenized [OPG study]6.6097767
GSM549136patient 036, cancer, homogenized [OPG study]7.7950478
GSM549140patient 044, cancer, homogenized [OPG study]7.8689279
GSM549111patient 047, normal, homogenized [OPG study]6.0467659
GSM549113patient 057, normal, homogenized [OPG study]5.1200944
GSM549132patient 031, cancer, homogenized [OPG study]6.8611670
GSM549137patient 038, cancer, homogenized [OPG study]7.5735177
GSM549142patient 047, cancer, homogenized [OPG study]6.7393368
GSM549100patient 110, normal, homogenized [OPG study]5.3063446
GSM549107patient 135, normal, homogenized [OPG study]5.5546751
GSM549115patient 068, normal, homogenized [OPG study]5.4998851
GSM549116patient 072, normal, homogenized [OPG study]5.1682844
GSM549120patient 078, normal, homogenized [OPG study]5.3654347
GSM549131patient 030, cancer, homogenized [OPG study]7.3722174
GSM549118patient 074, normal, homogenized [OPG study]4.932139
GSM549129patient 027, cancer, homogenized [OPG study]6.5825866
GSM549123patient 088, normal, homogenized [OPG study]5.3706248
GSM549124patient 006, cancer, homogenized [OPG study]6.7058968
GSM549126patient 015, cancer, homogenized [OPG study]6.9293171
GSM549128patient 025, cancer, homogenized [OPG study]6.943270
GSM549103patient 117, normal, homogenized [OPG study]4.5503729
GSM549117patient 073, normal, homogenized [OPG study]4.9954741
GSM549138patient 041, cancer, homogenized [OPG study]8.9028488
GSM549141patient 045, cancer, homogenized [OPG study]8.527785
GSM549130patient 028, cancer, homogenized [OPG study]7.4229376
GSM549101patient 111, normal, homogenized [OPG study]5.5938651
GSM549105patient 128, normal, homogenized [OPG study]5.0841541
GSM549106patient 134, normal, homogenized [OPG study]4.7983937
GSM549112patient 048, normal, homogenized [OPG study]5.0994442
GSM549125patient 011, cancer, homogenized [OPG study]6.614167
GSM549127patient 024, cancer, homogenized [OPG study]6.3077862
GSM549135patient 035, cancer, homogenized [OPG study]8.6176185